| Literature DB >> 32294883 |
Toshihiko Shoji1,2, Saeko Masumoto1,3, Nina Moriichi1, Yasuyuki Ohtake1,4, Tomomasa Kanda1,5.
Abstract
This clinical study was performed to evaluate the effects of continuous apple polyphenol (AP) administration on facial skin conditions and pigmentation induced by ultraviolet (UV) irradiation in healthy women participants. Participants (n = 65, age 20-39 years) were randomized to receive tablets containing AP (300 or 600 mg/day) or placebo in a double-blinded, placebo-controlled clinical trial. Continuous administration of AP for 12 weeks significantly prevented UV irradiation induced skin pigmentation (erythema value, melanin value, L value), although a dose-dependent relationship was not clearly observed. In contrast, no significant differences were detected between the groups with regard to water content and trans-epidermal water loss. Our study demonstrated that APs and their major active compounds, procyanidins, have several health benefits. Here, we report that continuous administration of AP for 12 weeks alleviated UV irradiation induced skin pigmentation, when compared with placebo, in healthy women.Entities:
Keywords: Apple polyphenols; UV irradiation; pigmentation; procyanidin; skin condition
Mesh:
Substances:
Year: 2020 PMID: 32294883 PMCID: PMC7231294 DOI: 10.3390/nu12041071
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Trial study design.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Precheck | ● | |||||||
| Visit to facility | ● | ● | ● | ● | ● | ● | ● | ● |
| Informed consent | ● | |||||||
| MED evaluation | ● | |||||||
| Evaluation of pigmentation | ||||||||
| UV-irradiation (1.5 MED) | ● | |||||||
| Erythema, melanin, L value | ● | ● | ● | ● | ● | ● | ● | |
| Evaluation of facial skin condition | ||||||||
| Water content, TEWL | ● | ● | ● | ● | ||||
| Ingestion of test sample |
| |||||||
| Recording in diary |
| |||||||
MED: minimal erythema dose; TEWL: trans-epidermal water loss. ●: visits for the measurement.
Figure 1CONSORT (Consolidated Standards of Reporting Trials) diagram. AP: apple polyphenols.
Baseline (0 weeks) characteristics of study participants.
| Apple Polyphenol Groups | Placebo Group | ||
|---|---|---|---|
| Low-Dose Group (300 mg/day) | High-Dose Group (600 mg/day) | ||
| N | 21 | 20 | 18 |
| Age (y) | 34.19 ± 4.29 | 35.20 ± 3.89 | 34.06 ± 4.08 |
| MED (mJ/cm2) | 5323.7 ± 478.0 | 5471.1 ± 499.7 | 5247.0 ± 531.7 |
| Water content (AU) | 88.56 ± 18.62 | 80.94 ± 14.33 | 85.32 ± 20.59 |
| TEWL (g/h m2) | 15.80 ± 5.85 | 16.12 ± 5.58 | 14.92 ± 5.10 |
Values are means ± standard deviation. None of the characteristics was different among the groups at baseline by the Tukey’s multiple comparisons test. MED: minimal erythema dose; TEWL: trans-epidermal water loss.
Effects of apple polyphenol (AP) on pigmentation induced by UV irradiation.
| Parameters | Groups | Intervention Period (Weeks since UV-Irradiation) | ||||||
|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 4 | 6 | 10 | ||
| Erythema value | Placebo | 175.6 ± 34.4 | 252.0 ± 40.3 ** | 237.3 ± 36.9 ** | 219.5 ± 34.7 ** | 222.5 ± 38.5 ** | 212.8 ± 31.9 * | 187.6 ± 35.4 |
| Low AP | 182.4 ± 32.0 | 225.5 ± 34.4 ** | 222.5 ± 31.9 ** | 224.0 ± 40.0 ** | 215.9 ± 41.5 * | 196.6 ± 31.8 | 184.0 ± 26.6 | |
| High AP | 179.5 ± 51.0 | 228.7 ± 43.5 ** | 225.0 ± 52.5 ** | 204.6 ± 40.0 | 206.1 ± 36.6 | 193.4 ± 42.8 | 176.2 ± 40.3 | |
| Melanin value | Placebo | 149.0 ± 33.3 | 192.2 ± 36.5 ** | 196.4 ± 38.4 ** | 194.7 ± 37.4 ** | 192.9 ± 36.8 ** | 189.9 ± 35.8 ** | 175.7 ± 32.1 |
| Low AP | 163.8 ± 29.5 | 194.9 ± 27.3 * | 194.9 ± 28.2 * | 193.0 ± 27.2 * | 190.0 ± 28.5 * | 189.2 ± 28.7 | 174.5 ± 23.3 | |
| High AP | 159.1 ± 36.6 | 188.6 ± 33.6 * | 191.1 ± 33.7 ** | 187.4 ± 31.7 | 184.3 ± 33.5 | 181.6 ± 33.2 | 172.5 ± 31.0 | |
| L value | Placebo | 64.4 ± 2.4 | 59.3 ± 2.7 ** | 60.0 ± 2.1 ** | 60.4 ± 2.0 ** | 60.6 ± 2.5 ** | 61.2 ± 2.1 ** | 62.5 ± 2.1 |
| Low AP | 64.4 ± 1.9 | 60.8 ± 2.4 ** | 61.2 ± 2.1 ** | 61.5 ± 1.8 ** | 61.6 ± 1.8 ** | 62.3 ± 1.6 * | 63.2 ± 1.9 | |
| High AP | 64.4 ± 2.7 | 60.4 ± 2.0 ** | 61.0 ± 2.5 ** | 61.1 ± 2.1 ** | 61.2 ± 2.0 ** | 61.9 ± 2.2 ** | 62.9 ± 2.2 ** | |
Values are means ± standard deviation. Significant differences within the groups were determined using repeated-measures of two-way ANOVA followed by the Dunnett’s multiple comparisons test (** p < 0.01, * p < 0.05).
Figure 2Apple polyphenol (AP) administration prevents increase in the erythema value. (A) Changes in erythema value in the placebo and AP groups. (B) Representative imaging of an irradiated area in the placebo group (upper) and AP groups (middle and lower) at 1 week after UV irradiation. Data are shown as means ± standard deviation. Significant differences among the groups were determined using repeated-measures of two-way ANOVA followed by Dunnett’s multiple comparisons test (* p < 0.05, ** p < 0.01).
Figure 3Apple polyphenol (AP) administration prevents increase in the melanin value. Changes in melanin value in the placebo and AP groups. Data are shown as means ± standard deviation. Significant differences among the groups were determined using repeated-measures of two-way ANOVA followed by the Dunnett’s multiple comparisons test (* p < 0.05, ** p < 0.01).
Figure 4Apple polyphenol (AP) administration prevents decrease in the L value. Changes in L value in the placebo and AP groups. Data are shown as means ± standard deviation. Significant differences among the groups were determined using repeated-measures of two-way ANOVA followed by Dunnett’s multiple comparisons test (* p < 0.05, ** p < 0.01).
Effects of apple polyphenol (AP) on water content and trans-epidermal water loss (TEWL) in facial skin.
| Parameters | Groups | Intervention Period (Weeks) | |||
|---|---|---|---|---|---|
| 0 | 4 | 8 | 12 | ||
| Water content (AU) | Placebo | 85.3 ± 20.6 | 89.6 ± 16.6 | 88.0 ± 16.9 | 92.0 ± 16.8 |
| Low AP | 88.6 ± 18.6 | 92.8 ± 16.6 | 91.8 ± 22.5 | 92.2 ± 15.8 | |
| High AP | 80.9 ± 14.3 | 86.7 ± 14.6 | 88.3 ± 13.9 | 91.3 ± 12.3 | |
| TEWL (g/h m2) | Placebo | 14.9 ± 5.1 | 14.6 ± 5.3 | 15.1 ± 6.2 | 13.6 ± 3.7 |
| Low AP | 15.8 ± 5.9 | 17.0 ± 6.9 | 15.9 ± 7.5 | 15.4 ± 7.6 | |
| High AP | 16.1 ± 5.6 | 16.2 ± 4.1 | 14.5 ± 4.3 | 14.8 ± 6.4 | |
Values are means ± standard deviation.